Sexually Transmitted Diseases (STD) Provider Education Grants

 

The purpose of the assistance is to fund academic institutions and clinical and public health training organizations to develop, deliver and evaluate training, and educational and clinical skills improvement activities for health care professionals and appropriate allied health personnel for the prevention, control and clinical management of gonorrhea, chlamydia, syphilis, and other STDs.

General information about this opportunity
Last Known Status
Active
Program Number
93.978
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Not applicable.
Authorization
Public Health Service Act 42 CFR Part 51b - PROJECT GRANTS FOR PREVENTIVE HEALTH SERVICES Section 318 (42 U.S. Code § 247c) Section 318 (42 U.S. Code § 247c) Sexually transmitted diseases; prevention and control projects; Sections 301(a), 317N, and 318 of the Public Health Service Act (42 U.S.C. Sections 241(a), 247b -15, and 247c)
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Academic institutions and national, state and Tribal clinical and public health training organizations.
Beneficiary Eligibility
Private and public clinical providers, such as physicians, nurse practitioners, nurses, physician assistants, pharmacists, and others.
Credentials/Documentation
Not applicable.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Award Procedure
After review and approval, a Notice of Award (NoA) is prepared and processed, along with appropriate notification to the public.
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 90 to 120 days.
Appeals
Not applicable.
Renewals
From 120 to 180 days. Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
How are proposals selected?
Applications will be evaluated on the need for the proposal and its potential benefit(s) to STD control; possible effects upon local STD control programs; consistency with national program goals; specific and measurable objectives; a workable and meaningful plan for evaluation; and a sound operational plan that ensures the proposal can be carried out to reach stated objectives.
How may assistance be used?
Cooperative agreement funds may be used to support academic institutions and clinical training organizations to develop, deliver and evaluate training, and educational and clinical skills improvement activities for health care professionals and allied health personnel for the prevention, control and clinical management of gonorrhea, chlamydia, syphilis, and other STD. Grant funds may be used for: (1) The costs associated with planning, organizing, and conducting professional STD education, training, and clinical skills improvement activities for health care providers and appropriate allied health personnel. Cooperative agreement funds may not be used for supplanting funds supporting existing STD control services provided by a State or locality. Proposals for applied research involving human subjects must follow current Public Health Service (PHS) and Centers for Disease Control and Prevention (CDC) guidelines on human experimentation.
What are the requirements after being awarded this opportunity?
Reporting
Performance Reports: Annual performance progress and monitoring reports will be expected from all recipients no later than 120 days prior to the end of each budget period. This report will serve as the continuation application for the follow-on budget period. The contents of the report should include the information specified in the solicitation from the CDC Grants Management Officer. See notice of funding opportunity (NOFO) for details.
Auditing
Not applicable.
Records
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with HHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Project period: From one to five years; budget period: 12 months. Method of awarding/releasing assistance: Lump.
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Megan B. Copeland
1600 Clifton Road, MS E-07
Atlanta, GA 30096 US
mzf3@cdc.gov
Phone: 4046398864

Nicolas Rankin
1600 Clifton Road, MS E-07
Atlanta, GA 30329 USA
xkx6@cdc.gov
Phone: 4044980226
Website Address
http://www.cdc.gov/std/
Financial Information
Account Identification
75-0943-0-1-550
Obligations
(Cooperative Agreements) FY 22$17,547,500.00; FY 23 est $11,565,000.00; FY 24 est $11,730,482.00; -
Range and Average of Financial Assistance
$300,000 to $1,715,000; Average: $628,000
Regulations, Guidelines and Literature
Not applicable.
Examples of Funded Projects
Not applicable.